Longitudinal Trajectories of Kidney Function in Patients with Severe ANCA-Associated Vasculitis

医学 肾脏疾病 内科学 血管炎 肾功能 置信区间 优势比 队列 队列研究 肾 不利影响 纵向研究 前瞻性队列研究 肾病科 逻辑回归 基线(sea) 肾功能受损 终末期肾病
作者
Jennifer S. Hanberg,Yuqing Zhang,Andreas Kronbichler,Anna Matyjek,Carol A. McAlear,Balazs Odler,Lisa Uchida,Duvuru Geetha,Carmel M. Hawley,David Jayne,Michael Walsh,Peter A. Merkel,Zachary S. Wallace,on behalf of the PEXIVAS investigators
出处
期刊:Clinical Journal of The American Society of Nephrology [Lippincott Williams & Wilkins]
卷期号:21 (2): 283-295
标识
DOI:10.2215/cjn.0000000881
摘要

Key Points We identified four kidney function trajectories in ANCA-associated vasculitis associated with varied risk of ESKD and CKD. Male sex, myeloperoxidase-ANCA specificity, baseline hypertension, and lower baseline eGFR were associated with adverse kidney function trajectory. Differences in baseline characteristics identify potential targets for personalized care. Background ANCA-associated vasculitis (AAV) causes GN culminating in a spectrum of CKD and ESKD. Kidney function trajectories with differing CKD risk were reported in a single-center study. We sought to confirm these findings in the Plasma Exchange and Glucocorticoids in Severe AAV trial cohort. Methods This cohort study included patients from Plasma Exchange and Glucocorticoids in Severe AAV with a baseline and one or more eGFR measurements over 36 months to identify groups with similar longitudinal change in kidney function using group-based trajectory analysis. We evaluated factors associated with group membership using multivariable-adjusted multinomial logistic regression. Results We identified four trajectory groups among 663 patients: early ESKD (113, 17%), stable impairment (400, 60%), impaired with improvement (131, 20%), and marked improvement (19, 3%). ESKD occurred in 137 patients (21%): 113 (100%) in the early ESKD, 23 (6%) in the stable impairment, and 1 (1%) in the impaired with improvement groups. Older baseline age (adjusted odds ratio [aOR], 0.97 per 1 year; 95% confidence interval [CI], 0.95 to 0.99), female sex (aOR, 0.54; 95% CI, 0.31 to 0.94), and baseline eGFR (aOR, 0.93 per 1 ml/min per 1.73 m 2 increase; 95% CI, 0.88 to 0.99) were associated with lower odds of early ESKD versus impaired with improvement membership. Myeloperoxidase-ANCA+ (aOR, 2.35; 95% CI, 1.33 to 4.16) and hypertension (aOR, 2.50; 95% CI, 1.33 to 4.69) were associated with higher odds of early ESKD membership. Conclusions We identified four kidney function trajectories in AAV associated with varied risk of ESKD and CKD; male sex, myeloperoxidase-ANCA specificity, baseline hypertension, and lower baseline eGFR were associated with adverse kidney function trajectory. Differences in baseline characteristics identify potential targets for personalized care.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
隐形曼青的应助被圈圈牙签儿采纳,获得10
刚刚
刚刚
1秒前
1秒前
2秒前
希望天下0贩的0的应助被aprewil采纳,获得10
2秒前
2秒前
3秒前
科研通AI6.2的应助被lipengjiajun采纳,获得10
3秒前
lu完成签到,获得积分20
4秒前
4秒前
zoiaii发布了新的文献求助10
5秒前
5秒前
渡人舟的应助被HAN采纳,获得10
6秒前
7秒前
聪慧大开发布了新的文献求助10
8秒前
隐形曼青的应助被ghost采纳,获得10
9秒前
文艺绮晴发布了新的文献求助10
9秒前
9秒前
10秒前
钉钉123456完成签到,获得积分10
10秒前
甜蜜从云关注了科研通微信公众号
10秒前
11秒前
11秒前
Orange的应助被维尼熊采纳,获得10
12秒前
qq完成签到,获得积分10
13秒前
14秒前
zoiaii完成签到,获得积分10
14秒前
14秒前
15秒前
玩家666发布了新的文献求助10
15秒前
失眠成危完成签到,获得积分10
15秒前
15秒前
均平和完成签到,获得积分10
16秒前
wangyumumu的应助被糕糕采纳,获得20
16秒前
16秒前
Horizon发布了新的文献求助10
17秒前
hua完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea De Guyane 2000
Energie-Contracting 1500
Stochastic Models in Operations Research,Vol. 2 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
Organizational Behavior 510
Stell & Maran's Head and Neck Surgery and Oncology 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8029808
求助须知:如何正确求助?哪些是违规求助? 9469556
关于积分的说明 21238100
捐赠科研通 7599956
什么是DOI,文献DOI怎么找? 3388383
关于科研通互助平台的介绍 2520730
邀请新用户注册赠送积分活动 2425150